evolocumab
Brand: REPATHA
approved
Quick answer
evolocumab (REPATHA), is a pharmaceutical active ingredient, with approved status in the US.
Key facts
- INN
- evolocumab
- Brand
- REPATHA
- Route
- INJECTION
- Formulation
- INJECTABLE
Related news
FDA Approves Repatha: Key Details on Amgen's Cardiovascular Drug
Repatha, recently approved by the FDA, is a groundbreaking treatment by Amgen for cardiovascular disease, targeting high cholesterol effectively.
FDA Approves Repatha for Pediatric Heterozygous Familial Hypercholesterolemia
The FDA has granted approval for Repatha, a groundbreaking treatment for pediatric patients suffering from heterozygous familial hypercholesterolemia, enhancing cholesterol control.
Frequently asked questions
What is evolocumab?
evolocumab (REPATHA), is a pharmaceutical active ingredient, with approved status in the US.
What is the brand name for evolocumab?
REPATHA is a marketed brand name for evolocumab. Check FDA Drugs@FDA for the current US label holder.